Does TAFAMIDIS MEGLUMINE Cause Off label use? 418 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 418 reports of Off label use have been filed in association with TAFAMIDIS MEGLUMINE (Vyndaqel). This represents 9.5% of all adverse event reports for TAFAMIDIS MEGLUMINE.
418
Reports of Off label use with TAFAMIDIS MEGLUMINE
9.5%
of all TAFAMIDIS MEGLUMINE reports
129
Deaths
100
Hospitalizations
How Dangerous Is Off label use From TAFAMIDIS MEGLUMINE?
Of the 418 reports, 129 (30.9%) resulted in death, 100 (23.9%) required hospitalization, and 2 (0.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFAMIDIS MEGLUMINE. However, 418 reports have been filed with the FAERS database.
What Other Side Effects Does TAFAMIDIS MEGLUMINE Cause?
Death (1,196)
Cardiac failure (519)
Dyspnoea (227)
Product use in unapproved indication (202)
Cardiac failure chronic (188)
Atrial fibrillation (164)
Fatigue (163)
Disease progression (157)
Condition aggravated (144)
Asthenia (125)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TAFAMIDIS MEGLUMINE Alternatives Have Lower Off label use Risk?
TAFAMIDIS MEGLUMINE vs TAFASITAMAB
TAFAMIDIS MEGLUMINE vs TAFASITAMAB-CXIX
TAFAMIDIS MEGLUMINE vs TAFINLAR
TAFAMIDIS MEGLUMINE vs TAFLUPROST
TAFAMIDIS MEGLUMINE vs TAGRAXOFUSP-ERZS